Navigation Links
New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
Date:11/21/2008

ne-height:1.5em; list-style-image: url(/images_v4/bullet_solid2.gif);">
  • dosage adjustment is recommended in patients with moderate or severe renal insufficiency and in patients with ESRD requiring hemodialysis or peritoneal dialysis. [See Dosage and Administration (2.2); Clinical Pharmacology (12.3).

    • Use with Medications Known to Cause Hypoglycemia

    • is typical with other antihyperglycemic agents used in combination with a sulfonylurea, when JANUVIA was used in combination with a sulfonylurea, a class of medications known to cause hypoglycemia, the incidence of hypoglycemia was increased over that of placebo. [See Adverse Reactions (6.1). Therefore, a lower dose of sulfonylurea may be required to reduce the risk of hypoglycemia. [See Dosage and Administration (2.3).

    • Hypersensitivity Reactions

    There have been postmarketing reports of serious hypersensitivity reactions in patients treated with JANUVIA. These reactions include anaphylaxis, angioedema, and exfoliative skin conditions including Stevens-Johnson syndrome. Because these reactions are reported voluntarily from a population of uncertain size, it is generally not possible to reliably estimate their frequency or establish a causal relationship to drug exposure. Onset of these reactions occurred within the first 3 months after initiation of treatment with JANUVIA, with some reports occurring after the first dose. If a hypersensitivity reaction is suspected, discontinue JANUVIA, assess for other potential causes for the event, and institute alternative treatment for diabetes. [See Adverse Reactions (6.2).

    '/>"/>

    Source: PRWeb
    Copyright©2008 Vocus, Inc.
    All rights reserved  

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine news :

    1. STAAR Surgical Forms Team of Leading Ophthalmic Surgeons to Study the Use of Collamer(R) Material for Accommodating Intraocular Lenses
    2. Landmark study defines benefits of early HIV testing and treatment for infected infants
    3. Study identifies causes of bone loss in breast cancer survivors
    4. New Study by BioTrends Highlights Practice Management Shifts Among Canadian Nephrologists
    5. Study Suggests Need for More Aggressive Outpatient Monitoring of Patients Hearts When Cause of Stroke is Unclear
    6. Rutgers researchers study cites media violence as critical risk factor for aggression
    7. Brigham and Womens Researchers Partner with Vocantas to use CallAssure in Clinical Research Study
    8. Analyst Available to Comment on New JUPITER Study That Shows AstraZenecas Crestor Significantly Reduces CV Risk
    9. New Study Finds CO2 Ablative Fractional Resurfacing Safe And Effective For Deep Acne Scarring
    10. Study investigates Gore-tex-type device to stop strokes and mini-strokes
    11. The smart way to study
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Related Image:
     New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes 
    New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
    (Date:12/6/2009)... Treatment site www.sleeping-with-a-sleeping-disorder.com is asking people ... natural sleep aids from around the world to ... cause. The submissions will be compiled in an ... YOU, to be sold from the website in ... of the proceeds ,from sales of the E-book ...
    (Date:12/6/2009)... Joseph W. Belluck of Belluck & Fox, LLP says dangerous substances ... seasons. , ... New York, NY (PRWEB) December 6, ... season, they should be alert to reports of recalls due to ... lawyer., , ,“Close to 230,000 children visit hospital emergency rooms each ...
    (Date:12/5/2009)... There have been significant scientific advances in the field ... a better understanding of how certain diseases progress in ... with the best care. Research presented today at the ... explores optimal induction therapies for managing multiple myeloma, the ...
    (Date:12/5/2009)... TOWN, South Africa, December 5 The first ... of Cape Town opened its doors,today (5 December ... by,Western Cape Premier Helen Zille, 2010 FIFA World ... South African Football Association,President Kirsten Nematandani and Executive ...
    (Date:12/5/2009)... Leukemia and myeloproliferative disorders are serious and ... the 51st Annual Meeting of the American Society ... improved diagnostic methods for patients suffering from acute ... leukemia, and myelofibrosis that are based on a ...
    Breaking Medicine News(10 mins):Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 2Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 3Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 4Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 5Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 6Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 7Health News:New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer 8Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 2Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 3Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 4Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 5Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 6Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 7Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 8Health News:Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders 9
    ... cancer. New research studies point towards its being preventable ... D and other vitamin D analogs, may help prevent ... at the American Association for Cancer Research's 4th annual ... ,The study funded by the National Institute of ...
    ... a donor sperm traces his genetic father using the DNA ... concerns about assisted reproduction that were not thought of when ... an unknown father using a donor sperm has succeeded in ... records and some ingenious Internet searches. ,The boy tracked ...
    ... new study says that a key enzyme present in skin ... the spread of the cancer to other parts of the ... is actually a critical component of the healthy cell and ... enzyme's less than helpful role in malignant melanoma or skin ...
    ... A dedicated 'organ transplant hospital' in the country ... a pioneering effort . ,Spread over a ... up by Hyderabad-based Global Hospitals Group,// headed by surgical gastro-enterologist ... hospital will have 750 beds and 150 full-time specialists in ...
    ... Zhengmin Chen and his team from Oxford University have ... heart attack patients may have more good effect in ... help in thinning of blood during a heart attack ... any serious side effects of bleeding. ,Researchers ...
    ... Downstate Medical Center in New York have discovered a ... the severity of atherosclerosis or blocked arteries.// ... teeth in 115 patients referred for transesophageal echocardiography (TEE) ... using this method. They also looked for the presence ...
    Other Medicine News:Health News:Anonymous Sperm Donor Traced On Internet 2Health News:Global Hospitals coming to city of Joy 2
    (Date:12/4/2009)... (NYSE Amex: PIP ), a biodefense company developing ... the presentation of new data from the Company,s anthrax ... (rPA) based anthrax vaccine is structurally stable and potent ... including 55 degrees C. The data were presented ...
    (Date:12/4/2009)... Suneva Medical, a privately-held aesthetic medical device company, today ... and Chief Financial Officer. In this role, Mr. ... functions including finance, accounting, IT, IR, administration and human ... senior management team. ,, "One of my key ...
    (Date:12/4/2009)... Drs. Neal Shore and E. David Crawford presented ... analysis of secondary end points of biochemical recurrence rate ... degarelix for injection) or monthly leuprolide in prostate cancer ... cancer patients who received FIRMAGON 240/80 mg/month had a ...
    Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 1November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 2November Is Report Card Month 3A Tutorgiant com Suggests That Online Tutoring May Be The Solution To Bad Report Cards 61487 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 1New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 2New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 3New Data Shows Obesity Costs Will Grow to 24344 Billion by 2018 61483 4Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 1Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 2Zyomyx Point of Care CD4 Test Selected by CD4 Initiative to Help Treat HIV AIDS Patients in Developing Countries 6315 3
    ... Patent,Foundation ("PUBPAT") announced today that the U.S. Patent & ... by Gilead Sciences,that relate to the drug known generically ... battle against HIV/AIDS. Gilead markets TDF in,the United States ... of its ATRIPLA,combination product., Roughly 40 million people ...
    ... Genome Sciences,Inc. (Nasdaq: HGSI ) announced today that ... of its ACHIEVE clinical trials of Albuferon(R) (albinterferon,alfa-2b) for ... who have,been receiving the 1200-mcg dose will now receive ... by the studies, independent Data,Monitoring Committee (DMC). HGS continues ...
    Other Medicine Technology:U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 2Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 3Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 4Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R) 5
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: